Allergan to Hold Special Meeting of Stockholders on Originally Scheduled Date of December 18 without Restriction

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that it has reached an agreement with Pershing Square Capital Management, L.P. (“Pershing Square”) and Valeant Pharmaceuticals (NYSE: VRX) (“Valeant”) under which Allergan will hold the Special Meeting of Stockholders (the “Special Meeting”) on the originally scheduled date of December 18, 2014, without restriction, and Pershing Square and Valeant will dismiss their pending litigation before the Delaware Court of Chancery. In connection, Allergan has established an October 30, 2014 record date for stockholders entitled to vote at the Special Meeting.